All News about Incyte Corp
![](/next-assets/images/schema-image-default.png)
Incyte's Earnings Outlook
July 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_19.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/09/stock-Incyte-01-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/02/incy.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Incyte
May 01, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Ominous Death Cross Forms On Incyte's Chart
April 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/24/sndx.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/19/jim_cramer_shutterstock2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/12/incy.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230711230393/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/11/sndx.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230711569566/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://g.foolcdn.com/editorial/images/737536/gettyimages-1027139762.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Via Talk Markets
![](https://mms.businesswire.com/media/20230525005514/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230518005001/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230508005263/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg)
![](https://mms.businesswire.com/media/20230502005266/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230501005479/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/21/incy.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230420005667/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://mms.businesswire.com/media/20230418005078/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230416005053/en/1762530/22/MorphoSys_Logo.jpg)
![](https://www.investors.com/wp-content/uploads/2023/04/TECH1_mifepristone_041423_newscom.jpg)
![](https://mms.businesswire.com/media/20230411005060/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.